Who owns DRUGS MADE IN AMER ACQUTN CO?
- Ticker: DMAA
- CUSIP Number: g2847j104
Tip: Access positions for across all investors
Analyze quarterly positions in Drugs Made In Amer Acqutn with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Drugs Made In Amer Acqutn stock
Who bought or sold DRUGS MADE IN AMER ACQUTN CO this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Karpus Investment Management | 2.5M | $27M | -1% | Jun 2026 |
|
| Mizuho Securities Usa | 2.0M | $21M | 0% | Jun 2026 |
|
| Highbridge Capital Management | 1.3M | $14M | 100% | Mar 2026 |
|
| Polar Securities | 1.1M | $12M | -28% | Jun 2026 |
|
| Glazer Capital | 1000k | $11M | -40% | Jun 2026 |
|
| Wolverine Asset Management | 832k | $8.9M | -46% | Jun 2026 |
|
| Vivaldi Asset Management | 787k | $8.4M | -65% | Jun 2026 |
|
| Heights Capital Management | 648k | $6.9M | 0% | Jun 2026 |
|
| Westchester Capital Management | 582k | $6.2M | -65% | Jun 2026 |
|
| Clear Street Group | 382k | $1.6M | 8% | Jun 2026 |
|
| Aristeia Capital | 350k | $3.7M | -60% | Jun 2026 |
|
| Sona Asset Management | 163k | $1.7M | 0% | Jun 2026 |
|
| RLH Capital | 116k | $1.2M | -63% | Jun 2026 |
|
| Logan Stone Capital | 110k | $1.2M | 100% | Jun 2026 |
|
| Toronto-Dominion Bank | 100k | $1.1M | -51% | Jun 2026 |
|
| Meteora Capital | 98k | $1.0M | -74% | Jun 2026 |
|
| Quarry | 66k | $698k | -75% | Jun 2026 |
|
| Geode Capital Management | 62k | $663k | 0% | Jun 2026 |
|
| Jpmorgan Chase & Co | 50k | $531k | -96% | Jun 2026 |
|
| Oakmont Partners | 36k | $388k | 0% | Jun 2026 |
|
| Lineage Point Capital | 32k | $339k | 0% | Jun 2026 |
|
| Hrt Financial | 19k | $196k | -33% | Jun 2026 |
|
| Morgan Stanley | 58.00 | $608.002400 | -52% | Mar 2026 |
|
Who sold out of Drugs Made In Amer Acqutn?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| D. E. Shaw & Co | Mar 2026 | 690k | $7.2M |
| Shaolin Capital Management | Mar 2026 | 550k | $5.8M |
| Radcliffe Capital Management | Mar 2026 | 547k | $5.7M |
| LMR Partners | Mar 2026 | 500k | $5.2M |
| Rivernorth Capital Management | Mar 2026 | 418k | $4.4M |
| Whitebox Advisors | Mar 2026 | 400k | $4.2M |
| CNH Partners | Mar 2026 | 358k | $3.8M |
| Hudson Bay Capital Management | Mar 2026 | 298k | $3.1M |
| Governors Lane | Mar 2026 | 250k | $2.6M |
| Context Capital Management | Mar 2026 | 250k | $2.6M |
| Goldman Sachs Group | Mar 2026 | 120k | $1.3M |
| DLD Asset Management | Mar 2026 | 101k | $1.1M |
| Warberg Asset Management | Mar 2026 | 92k | $966k |
| Periscope Capital | Mar 2026 | 50k | $525k |
| Bnp Paribas Arbitrage, Snc | Mar 2026 | 15k | $154k |
| Citadel Advisors | Mar 2026 | 11k | $110k |